Literature DB >> 1346574

Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting.

M Okamoto1, T Yamamoto, S Matsubara, I Kukita, M Takeya, Y Miyauchi, T Kambara.   

Abstract

Blood coagulation or plasma clotting caused generation of a monocyte chemotactic factor(s) in vitro. The chemotactic factor, of which the apparent molecular mass was 75 kDa, shared antigenicity with complement C5 and possessed the affinity to monocytes, but not to polymorphonuclear leukocytes. The generation of the chemotactic factor was hindered in the presence of a thiol enzyme inhibitor, p-chloromercuriphenyl sulfonic acid, at the concentration of 1 mmol/l, although the gelation of plasma was apparently completed. Furthermore, the generation of chemotactic factor was not observed when a plasma deficient in blood coagulation factor XIII, which is a precursor of a thiol enzyme, plasma transglutaminase, was used; and the activity normally appeared when the deficient plasma was reconstituted with purified factor XIII or with a tissue transglutaminase prior to clotting. When the human sera were injected into guinea pig skin, the serum derived from normal plasma or from the reconstituted factor XIII deficient one caused mononuclear cell infiltration, however, the serum from the deficient plasma without reconstitution infiltrated to a significantly smaller extent. These results indicated that the complement system was initiated somehow during the clotting process resulting in the generation of the C5-derived monocyte chemotactic factor in cooperation with factor XIIIa (activated factor XIII).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346574     DOI: 10.1016/0925-4439(92)90151-c

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Kathryn E Hulse; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-03-28       Impact factor: 10.793

2.  Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.

Authors:  Camilla Lund Nikolajsen; Thomas F Dyrlund; Ebbe Toftgaard Poulsen; Jan J Enghild; Carsten Scavenius
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

3.  Detection of guinea pig macrophages by a new CD68 monoclonal antibody, PM-1K.

Authors:  Tomohiro Horikawa; Yoshihiro Komohara; Emi Kiyota; Yasuhiro Terasaki; Katsumasa Takagi; Motohiro Takeya
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

4.  A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation.

Authors:  Umeko Semba; Jun Chen; Yoshihiko Ota; Nan Jia; Hidetoshi Arima; Hiroshi Nishiura; Tetsuro Yamamoto
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

5.  RP S19 C-terminal peptide trimer acts as a C5a receptor antagonist.

Authors:  Hiroshi Nishiura; Toru Kawakami; Mutsuki Kawabe; Nahoko Kato-Kogoe; Naoko Yamada; Keiji Nakasho; Koji Yamanegi
Journal:  Biochem Biophys Rep       Date:  2016-05-10

Review 6.  Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.

Authors:  Fahad S M Alshehri; Claire S Whyte; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.